Article Details
Retrieved on: 2021-01-07 09:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... with POINT Biopharma Inc., to provide access to Avacta's pre|CISION technology for the development of tumour-activated radiopharmaceuticals.
Article found on: www.cambridgenetwork.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here